Monitor for any future conversion to Schedule 13D or changes in Qiming's stake; the passive filing suggests no imminent activist activity.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 4 $0.7805entry
- T+1 · 12d ago −6.25%α −1.84% · $0.7317
- T+5 · 6d ago −11.74%α −10.82% · $0.6889
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Qiming Managing Directors Fund V, L.P. and related Qiming entities filed an amended Schedule 13G disclosing an aggregate beneficial ownership of 2,757,490 ordinary shares (4.4% of shares outstanding as of July 31, 2026) in Connect Biopharma Holdings Ltd, up from a prior stake. The filing reflects a routine passive stake update with no change in investment intent.
Key Financial Metrics
Key Facts
- Qiming Managing Directors Fund V, L.P. and related entities filed an amended Schedule 13G on November 3, 2026.
- Aggregate beneficial ownership: 2,757,490 ordinary shares, representing 4.4% of shares outstanding as of July 31, 2026.
- The filing is an amendment to a prior Schedule 13G, indicating a passive investment stance.
- The stake is held across multiple Qiming funds: Qiming Venture Partners V, L.P. (1,766,600 shares, 2.8%), Qiming Venture Partners VII, L.P. (926,527 shares, 1.5%), Qiming Managing Directors Fund V, L.P. (54,826 shares, 0.1%), and Qiming VII Strategic Investors Fund, L.P. (8,537 shares, 0.0%).
- The percentage is based on 62,974,309 ordinary shares outstanding as of July 31, 2026, per the issuer's Form 10-Q.
Financial Impact
Qiming entities hold 4.4% of Connect Biopharma, a passive stake with no stated change in investment intent.
Risk Factors
- No material financial data provided in the filing; the stake is passive and routine.
- No indication of intent to influence management or strategy.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001664985-26-000003 |
| Document: 0001664985-26-000003-index.html | 0001664985-26-000003 |
| Document: 0001664985-26-000003.txt | 0001664985-26-000003 |
Track record
12 reports on CNTB
2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +22.39% at T+20 after the May 12, 2026 report. 2 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $0.5873 Now $0.6430 +9.48% settles Nov 24
- Nov 16, 2026today Press Release Neutral 6/10 Entry $0.6430 Now $0.6430 +0.00% settles Nov 24
- Nov 3, 202613d ago SC 13G/A Neutral 2/10 Viewing Entry $0.7805 to $0.6889 Now $0.6430 −17.62% ▼ −11.74% −10.82% vs SPY
- Oct 6, 20265w ago SC 13G Neutral 3/10 Entry $0.9450 to $0.9090 Now $0.6430 −31.96% ▼ −3.81% −2.83% vs SPY
- Sep 30, 20266w ago 8-K Bullish 7/10 Entry $1.10 to $0.9450 Now $0.6430 −41.55% ▼ −14.09% −16.00% vs SPY
- Sep 30, 20266w ago Press Release Bullish 7/10 Entry $1.10 to $0.9447 Now $0.6430 −41.55% ▼ −14.12% −16.03% vs SPY
- Sep 15, 20268w ago 8-K Mixed 6/10 Entry $1.17 to $1.28 Now $0.6430 −45.04% ▲ +9.40% +8.58% vs SPY
- May 12, 202626w ago 8-K Neutral 4/10 No price data
- May 12, 202626w ago Press Release Bearish 6/10 Entry $2.68 to $2.38 Now $0.6430 +76.01% ▲ +11.19% +11.27% vs SPY
- Apr 23, 202629w ago 8-K Bullish 7/10 Entry $2.52 to $2.53 Now $0.6430 −74.48% ▲ +0.40% −1.08% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers